Utah woman says clinical trial cured her hepatitis C

Utah woman says clinical trial cured her hepatitis C
SALT LAKE CITY — Researchers at Intermountain Medical Center said they found a cure for hepatitis C, a common virus. The hospital led the worldwide 12 to 24 week clinical trial, testing 660 patients, half of them from the U.S.. Utah resident Gina …
Read more here.

Hepatitis C drug can cure, if patients can get it
A wonder drug came on the market two years ago that cures hepatitis C, a potentially deadly liver disease afflicting millions of Americans, killing 15,000 a year. The problem is, many patients could not afford it. A standard course of Sovaldi cost $ 84 …
Read more here.

WO resident benefits from new drug that cures hepatitis C
WEST ORANGE, NJ — One West Orange resident had a special reason to be grateful World Hepatitis Day on July 28, having recently been cured of his chronic hepatitis C, after suffering from it for 15 years, thanks to a new prescription drug that has …
Read more here.

Gilead Won't Run Out of Hep C Patients, or Dollars, Anytime Soon
A single pill of Gilead Sciences Inc.'s hepatitis C treatment costs more than an iPhone, and is selling better, too. In the drug's first full year on the market in 2014, Sovaldi — which costs $ 1,000 a pill — brought in $ 10.3 billion. That's more than …
Read more here.

Ask the Expert: Hepatitis C cure
One of the biggest problems is that the symptoms of hep C don't often show up until it's at a very advanced stage. There are certain populations that should be tested and that can happen right in the doctor's office. Those populations include IV drug …
Read more here.

Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Merck & Co. plans to target hard-to-treat hepatitis C patients with its cure for the liver ailment rather than compete for market share by drastically undercutting the price of Gilead Sciences Inc.'s $ 1,000-a-day treatment. Merck said Tuesday that the …
Read more here.

World Hepatitis Day: We have a cure for Hepatitis C, but it's not offered to
Hepatitis C is a silent killer, a virus isolated as recently as 1989 when an infection damaging the liver was identified which wasn't Hepatitis A or B. Up to 150 million people live with the virus globally, many without realising it and approximately …
Read more here.

Pricier treatment overtakes 00-per-pill hepatitis C drug
The fast-paced changes in hepatitis C treatment are being watched closely amid fears that breakthrough drugs could reignite the rise of U.S. health care costs. Other medications that could turn into cost drivers include a new treatment for melanoma and …
Read more here.

FDA OK's BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb's (BMS) NS5A inhibitor Daklinza (daclatasvir) to be used in combination with Gilead Sciences' Sovaldi (sofosbuvir) to treat genotype 3 of hepatitis C. This is the first hep C …
Read more here.


Leave a Reply